Zeena Eblimit
Overview
Explore the profile of Zeena Eblimit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walters J, Schouest B, Patel A, Reuschel E, Schultheis K, Parzych E, et al.
Vaccine
. 2022 Apr;
40(21):2960-2969.
PMID: 35428500
The enhanced transmissibility and immune evasion associated with emerging SARS-CoV-2 variants demands the development of next-generation vaccines capable of inducing superior protection amid a shifting pandemic landscape. Since a portion...
2.
Patel A, Walters J, Reuschel E, Schultheis K, Parzych E, Gary E, et al.
Cell Rep Med
. 2021 Oct;
2(10):100420.
PMID: 34604818
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic global impact on public health and social and economic infrastructures. Here, we assess the immunogenicity and anamnestic...
3.
Eblimit Z, Thevananther S, Karpen S, Taegtmeyer H, Moore D, Adorini L, et al.
Cardiovasc Ther
. 2018 Aug;
36(5):e12462.
PMID: 30070769
Introduction: Administration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice....
4.
Desai M, Mathur B, Eblimit Z, Vasquez H, Taegtmeyer H, Karpen S, et al.
Hepatology
. 2016 Oct;
65(1):189-201.
PMID: 27774647
Conclusions: Decreased proliferator-activated receptor-γ coactivator 1α expression contributes to the metabolic dysfunction in cholecardia so that reducing serum bile acid concentrations may be beneficial against the metabolic and pathological changes...
5.
Desai M, Eblimit Z, Thevananther S, Kosters A, Moore D, Penny D, et al.
Liver Int
. 2013 Dec;
35(4):1464-77.
PMID: 24330504
Background: Triggers and exacerbants of cirrhotic cardiomyopathy (CC) are poorly understood, limiting treatment options in patients with chronic liver diseases. Liver transplantation alone reverses some features of CC, but the...